Lineage Cell Therapeutics LCTX
NYSE LCTX
$1.00 +0.02 (+2.04%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Lineage Cell Therapeutics 252.91 Mn 51.31 Mn - 14.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.50 Mn
Mar 31, 2026 5.97 Mn
Mar 31, 2025 2.00 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 4.00 Mn
Dec 31, 2023 9.83 Mn
Sep 30, 2023 11.86 Mn
Jun 30, 2023 48.66 Mn
Mar 31, 2023 46.66 Mn
Mar 31, 2021 10.06 Mn
Dec 31, 2020 94,000.00
Sep 30, 2020 211,000.00
Jun 30, 2020 6.71 Mn
Mar 31, 2020 5.22 Mn
Dec 31, 2019 148,000.00
Mar 31, 2018 3.22 Mn
API Access

Lineage Cell Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=LCTX&period=max&api_key=YOUR_API_KEY